- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
- Volume is elevated versus the 13-week average, confirming attention.
301047
SHZ
Week ended 07 Aug 2026
Weekly Investor Report
Sino Biological,Inc. · Healthcare · Biotechnology
Latest close
107.9 CNY
59.8%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is 52.9% above the Trend Line and sits at 100.0% of its 52-week range. The latest completed week returned 59.8%, after a 54.0% four-week move. The latest news-sentiment score is 50/100. Near-term considerations: price is close to its 52-week high.
Setup score
63
out of 100
Latest Close
107.9 CNY
7 Aug 2026
1W Return
59.8%
latest completed week
4W Return
54.0%
short-term follow-through
12W Return
56.2%
quarterly tape
Trend Breadth
50.0%
26 of 52 weeks active
Volume Ratio
5.3x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Next-week expectancy is negative at 41.52% based on similar historical setup states.
- Activity pressure is weak, so confirmation is not yet broad enough.
- 1 reversal markers appear in the recent smart-money tape.
- Price is close to its 52-week high; watch for continuation or exhaustion.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
59.8%
Latest completed week; four-week move 54.0%.
Indicator stack
28/82
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 41.52%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
0 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is 52.9% above the Trend Line and sits at 100.0% of its 52-week range. The latest completed week returned 59.8%, after a 54.0% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 5.3x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
6 Feb
13 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.1212-week average 0.24
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure3/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership1/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.12Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers11 reversal markers
No recent accumulation markers. 1 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 54.0% over four weeks, 56.2% over 12 weeks, and 58.5% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year26
Trend breadth50.0%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.76Latest activity-pressure read.
Pressure change234.6%Four-week change in activity pressure.
Leadership47.76Latest relative-leadership reading.
RS change607.8%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 0 relevant articles.
0 positive · 0 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown0.0%Distance below the 52-week high.
13-week volatility16.7%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
6 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher11 of 2615 weeks finished lower.
Best week+59.8%Week of 7 Aug.
Worst week-5.3%Week of 29 May.
Latest week+59.8%Week of 7 Aug.
Shape of recent returns
Strong gains2
Modest gains9
Flat weeks0
Modest losses14
Sharp losses1
Recent vol16.7%13-week weekly-return volatility.
Base vol9.1%52-week weekly-return volatility.
Up/down split24/28Count of positive and negative weeks in the 52-week window.
Average skew5.4% / -2.3%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorCN Healthcare
4-week rank- / 100
Group average4.8%
Trend breadth21.0%
Trend21.0%active weekly trend signals
MD64.0%positive activity pressure
RS31.0%positive relative leadership
Four-week leaders
IndustryCN Biotechnology
4-week rank1 / 100
Group average4.5%
Trend breadth15.0%
Trend15.0%active weekly trend signals
MD37.0%positive activity pressure
RS32.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape55/100
Trend, activity pressure, participation, and risk combine to a 55/100 tape read.
Indicator analysis15/100Latest 12-week confirmation: trend 0/12, activity pressure 3/12, relative leadership 1/12.
Activity pressure 0.12; 1 reversal markers Next-Week ExpectancyNegative 41.52%Next-week expectancy is negative with a 41.52% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 0 relevant articles.
Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 107.9 CNY | 59.8% | 70.57 CNY | 66.09 CNY | 0.76 | 47.76 | 49.2M | Off |
| 31 Jul 2026 | 67.50 CNY | -1.2% | 69.19 CNY | 65.91 CNY | 0.50 | -2.06 | 7.2M | Off |
| 24 Jul 2026 | 68.30 CNY | -2.1% | 69.15 CNY | 65.97 CNY | 0.35 | -2.77 | 12.8M | Off |
| 17 Jul 2026 | 69.76 CNY | -0.4% | 69.07 CNY | 66.03 CNY | -0.10 | -0.64 | 19.4M | Off |
| 10 Jul 2026 | 70.07 CNY | 0.5% | 68.95 CNY | 66.07 CNY | -0.57 | -9.41 | 9.5M | Off |
| 3 Jul 2026 | 69.69 CNY | 14.9% | 68.86 CNY | 66.12 CNY | -1.02 | -13.55 | 2.1M | Off |
| 26 Jun 2026 | 60.64 CNY | 0.1% | 68.78 CNY | 66.18 CNY | -1.31 | -26.03 | 1.0M | Off |
| 19 Jun 2026 | 60.59 CNY | 0.8% | 68.97 CNY | 66.30 CNY | -1.29 | -27.75 | 2.9M | Off |
| 12 Jun 2026 | 60.12 CNY | -1.7% | 69.45 CNY | 66.46 CNY | -1.28 | -23.78 | 710.9K | Off |
| 5 Jun 2026 | 61.16 CNY | -3.3% | 69.89 CNY | 66.62 CNY | -1.09 | -24.74 | 726.6K | Off |
| 29 May 2026 | 63.25 CNY | -5.3% | 70.34 CNY | 66.77 CNY | -0.98 | -23.98 | 4.1M | Off |
| 22 May 2026 | 66.80 CNY | -3.3% | 70.60 CNY | 66.93 CNY | -0.96 | -20.32 | 3.9M | Off |
| 15 May 2026 | 69.07 CNY | -2.7% | 70.70 CNY | 67.06 CNY | -0.84 | -17.78 | 6.8M | Off |
| 8 May 2026 | 70.96 CNY | 1.6% | 70.81 CNY | 67.20 CNY | -0.57 | -15.86 | 3.6M | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.